JBIO
Price
$11.14
Change
+$0.34 (+3.15%)
Updated
Jul 3 closing price
Capitalization
359.11M
35 days until earnings call
OPT
Price
$3.41
Change
+$0.23 (+7.23%)
Updated
Mar 17 closing price
Capitalization
524.82M
52 days until earnings call
Interact to see
Advertisement

JBIO vs OPT

Header iconJBIO vs OPT Comparison
Open Charts JBIO vs OPTBanner chart's image
Jade Biosciences
Price$11.14
Change+$0.34 (+3.15%)
Volume$110.75K
Capitalization359.11M
Opthea
Price$3.41
Change+$0.23 (+7.23%)
Volume$3.03K
Capitalization524.82M
JBIO vs OPT Comparison Chart in %
Loading...
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBIO vs. OPT commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a Hold and OPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (JBIO: $11.14 vs. OPT: $3.41)
Brand notoriety: JBIO and OPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 25% vs. OPT: 100%
Market capitalization -- JBIO: $359.11M vs. OPT: $524.82M
JBIO [@Biotechnology] is valued at $359.11M. OPT’s [@Biotechnology] market capitalization is $524.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green whileOPT’s FA Score has 0 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • OPT’s FA Score: 0 green, 5 red.
According to our system of comparison, JBIO is a better buy in the long-term than OPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 3 TA indicator(s) are bullish.

  • JBIO’s TA Score: 3 bullish, 5 bearish.

Price Growth

JBIO (@Biotechnology) experienced а +20.43% price change this week, while OPT (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.59%. For the same industry, the average monthly price growth was +13.92%, and the average quarterly price growth was -0.53%.

Reported Earning Dates

JBIO is expected to report earnings on Aug 11, 2025.

OPT is expected to report earnings on Aug 28, 2025.

Industries' Descriptions

@Biotechnology (+5.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPT($525M) has a higher market cap than JBIO($359M). JBIO YTD gains are higher at: 320.377 vs. OPT (-13.176).
JBIOOPTJBIO / OPT
Capitalization359M525M68%
EBITDAN/A-218.88M-
Gain YTD320.377-13.176-2,431%
P/E RatioN/AN/A-
RevenueN/A87.7K-
Total CashN/A132M-
Total DebtN/A157M-
FUNDAMENTALS RATINGS
OPT: Fundamental Ratings
OPT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBIOOPT
RSI
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
Momentum
ODDS (%)
Bullish Trend 5 days ago
89%
N/A
MACD
ODDS (%)
Bullish Trend 5 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
71%
Advances
ODDS (%)
Bullish Trend 18 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRLEF0.03N/A
+5.63%
Trillion Energy International Inc.
UMICY4.160.01
+0.23%
Umicore SA
VWAGY10.990.02
+0.18%
Volkswagen AG
STXPF0.11N/A
N/A
STUHINI EXPL LTD.
BJTRF0.65N/A
N/A
Beijing Tong Ren Tang Chinese Medicine Co Ltd, Hong Kong

JBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been closely correlated with OVID. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBIO jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
+3.15%
OVID - JBIO
79%
Closely correlated
+2.39%
KNSA - JBIO
35%
Loosely correlated
+1.60%
SYRE - JBIO
29%
Poorly correlated
+1.68%
KPRX - JBIO
29%
Poorly correlated
-0.35%
OPT - JBIO
27%
Poorly correlated
N/A
More

OPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPT has been loosely correlated with PSTV. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OPT jumps, then PSTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPT
1D Price
Change %
OPT100%
N/A
PSTV - OPT
36%
Loosely correlated
-3.52%
TNYA - OPT
34%
Loosely correlated
N/A
OVID - OPT
31%
Poorly correlated
+2.39%
JBIO - OPT
27%
Poorly correlated
+3.15%
KYTX - OPT
25%
Poorly correlated
-0.53%
More